newsfilter
← Latest News
ACCESS Newswire·

Edesa Biotech Announces One-for-Seven Reverse Share Split

TORONTO, ON / ACCESSWIRE / October 10, 2023 / Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on inflammatory and immune-related